Immunomodulation by viruses: The myxoma virus story

Piers Nash, John Barrett, Cao Jing-Xin, Sheela Hota-Mitchell, Alshad S. Lalani, Helen Everett, Xu Xiao-Ming, Janine Robichaud, Shawna Hnatiuk, Cheryl Ainslie, Bruce T. Seet, Douglas McFadden

Research output: Contribution to journalReview article

108 Citations (Scopus)

Abstract

Myxoma virus is a poxvirus pathogen of rabbits that has evolved to replicate successfully in the presence of an active immune response by an infected host. To accomplish this, the virus has developed a variety of strategies to avoid detection by or obstruct specific aspects of the antiviral response whose consolidated action is antagonistic to virus survival. We describe two distinct viral strategies carried out by viral proteins with which myxoma virus subverts the host immune response. The first strategy is the production of virus-encoded proteins known as viroceptors or virokines that mimic host receptors or cytokines. These seek to actively block extracellular immune signals required for effective virus clearance and produce a local environment in the infected tissue that is 'virus friendly'. The second strategy carried out by intracellular viral proteins, seeks to retard the innate antiviral responses such as apoptosis, and hinder attempts by the infected cell to communicate with the cellular arm of the immune system. By studying these viral strategies of immune evasion, the myxoma system can provide insights into virus-host interactions and also provide new insights into the complex immune system.

Original languageEnglish (US)
Pages (from-to)103-120
Number of pages18
JournalImmunological Reviews
Volume168
DOIs
StatePublished - Jun 24 1999
Externally publishedYes

Fingerprint

Myxoma virus
Immunomodulation
Viruses
Viral Proteins
Antiviral Agents
Immune System
Active Immunity
Poxviridae
Immune Evasion
Myxoma
Cytokine Receptors
Apoptosis
Rabbits

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Nash, P., Barrett, J., Jing-Xin, C., Hota-Mitchell, S., Lalani, A. S., Everett, H., ... McFadden, D. (1999). Immunomodulation by viruses: The myxoma virus story. Immunological Reviews, 168, 103-120. https://doi.org/10.1111/j.1600-065X.1999.tb01286.x

Immunomodulation by viruses : The myxoma virus story. / Nash, Piers; Barrett, John; Jing-Xin, Cao; Hota-Mitchell, Sheela; Lalani, Alshad S.; Everett, Helen; Xiao-Ming, Xu; Robichaud, Janine; Hnatiuk, Shawna; Ainslie, Cheryl; Seet, Bruce T.; McFadden, Douglas.

In: Immunological Reviews, Vol. 168, 24.06.1999, p. 103-120.

Research output: Contribution to journalReview article

Nash, P, Barrett, J, Jing-Xin, C, Hota-Mitchell, S, Lalani, AS, Everett, H, Xiao-Ming, X, Robichaud, J, Hnatiuk, S, Ainslie, C, Seet, BT & McFadden, D 1999, 'Immunomodulation by viruses: The myxoma virus story', Immunological Reviews, vol. 168, pp. 103-120. https://doi.org/10.1111/j.1600-065X.1999.tb01286.x
Nash P, Barrett J, Jing-Xin C, Hota-Mitchell S, Lalani AS, Everett H et al. Immunomodulation by viruses: The myxoma virus story. Immunological Reviews. 1999 Jun 24;168:103-120. https://doi.org/10.1111/j.1600-065X.1999.tb01286.x
Nash, Piers ; Barrett, John ; Jing-Xin, Cao ; Hota-Mitchell, Sheela ; Lalani, Alshad S. ; Everett, Helen ; Xiao-Ming, Xu ; Robichaud, Janine ; Hnatiuk, Shawna ; Ainslie, Cheryl ; Seet, Bruce T. ; McFadden, Douglas. / Immunomodulation by viruses : The myxoma virus story. In: Immunological Reviews. 1999 ; Vol. 168. pp. 103-120.
@article{9b0ac84093a04c63b65080002b662df1,
title = "Immunomodulation by viruses: The myxoma virus story",
abstract = "Myxoma virus is a poxvirus pathogen of rabbits that has evolved to replicate successfully in the presence of an active immune response by an infected host. To accomplish this, the virus has developed a variety of strategies to avoid detection by or obstruct specific aspects of the antiviral response whose consolidated action is antagonistic to virus survival. We describe two distinct viral strategies carried out by viral proteins with which myxoma virus subverts the host immune response. The first strategy is the production of virus-encoded proteins known as viroceptors or virokines that mimic host receptors or cytokines. These seek to actively block extracellular immune signals required for effective virus clearance and produce a local environment in the infected tissue that is 'virus friendly'. The second strategy carried out by intracellular viral proteins, seeks to retard the innate antiviral responses such as apoptosis, and hinder attempts by the infected cell to communicate with the cellular arm of the immune system. By studying these viral strategies of immune evasion, the myxoma system can provide insights into virus-host interactions and also provide new insights into the complex immune system.",
author = "Piers Nash and John Barrett and Cao Jing-Xin and Sheela Hota-Mitchell and Lalani, {Alshad S.} and Helen Everett and Xu Xiao-Ming and Janine Robichaud and Shawna Hnatiuk and Cheryl Ainslie and Seet, {Bruce T.} and Douglas McFadden",
year = "1999",
month = "6",
day = "24",
doi = "10.1111/j.1600-065X.1999.tb01286.x",
language = "English (US)",
volume = "168",
pages = "103--120",
journal = "Immunological Reviews",
issn = "0105-2896",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Immunomodulation by viruses

T2 - The myxoma virus story

AU - Nash, Piers

AU - Barrett, John

AU - Jing-Xin, Cao

AU - Hota-Mitchell, Sheela

AU - Lalani, Alshad S.

AU - Everett, Helen

AU - Xiao-Ming, Xu

AU - Robichaud, Janine

AU - Hnatiuk, Shawna

AU - Ainslie, Cheryl

AU - Seet, Bruce T.

AU - McFadden, Douglas

PY - 1999/6/24

Y1 - 1999/6/24

N2 - Myxoma virus is a poxvirus pathogen of rabbits that has evolved to replicate successfully in the presence of an active immune response by an infected host. To accomplish this, the virus has developed a variety of strategies to avoid detection by or obstruct specific aspects of the antiviral response whose consolidated action is antagonistic to virus survival. We describe two distinct viral strategies carried out by viral proteins with which myxoma virus subverts the host immune response. The first strategy is the production of virus-encoded proteins known as viroceptors or virokines that mimic host receptors or cytokines. These seek to actively block extracellular immune signals required for effective virus clearance and produce a local environment in the infected tissue that is 'virus friendly'. The second strategy carried out by intracellular viral proteins, seeks to retard the innate antiviral responses such as apoptosis, and hinder attempts by the infected cell to communicate with the cellular arm of the immune system. By studying these viral strategies of immune evasion, the myxoma system can provide insights into virus-host interactions and also provide new insights into the complex immune system.

AB - Myxoma virus is a poxvirus pathogen of rabbits that has evolved to replicate successfully in the presence of an active immune response by an infected host. To accomplish this, the virus has developed a variety of strategies to avoid detection by or obstruct specific aspects of the antiviral response whose consolidated action is antagonistic to virus survival. We describe two distinct viral strategies carried out by viral proteins with which myxoma virus subverts the host immune response. The first strategy is the production of virus-encoded proteins known as viroceptors or virokines that mimic host receptors or cytokines. These seek to actively block extracellular immune signals required for effective virus clearance and produce a local environment in the infected tissue that is 'virus friendly'. The second strategy carried out by intracellular viral proteins, seeks to retard the innate antiviral responses such as apoptosis, and hinder attempts by the infected cell to communicate with the cellular arm of the immune system. By studying these viral strategies of immune evasion, the myxoma system can provide insights into virus-host interactions and also provide new insights into the complex immune system.

UR - http://www.scopus.com/inward/record.url?scp=0033037558&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033037558&partnerID=8YFLogxK

U2 - 10.1111/j.1600-065X.1999.tb01286.x

DO - 10.1111/j.1600-065X.1999.tb01286.x

M3 - Review article

C2 - 10399068

AN - SCOPUS:0033037558

VL - 168

SP - 103

EP - 120

JO - Immunological Reviews

JF - Immunological Reviews

SN - 0105-2896

ER -